Physiological Changes in Hematological Parameters During Pregnancy

Received 2012 Apr 14; Accepted 2012 Jun 21; Issue date 2012 Sep.

What Does It Mean When Neutrophils Are High During Pregnancy?

Neutrophils are white blood cells that help our bodies fight infection. Neutrophils can be high during pregnancy due to the extra stress that pregnancy puts on a person’s body.

A high neutrophil count during pregnancy is usually normal. However, high neutrophils can sometimes point to an underlying condition, such as gestational diabetes.

This article explains the reasons for high neutrophils during pregnancy. It covers the symptoms you may experience when your neutrophils are high, and when to see a healthcare provider.

LWA/Dann Tardif/Getty Images

What Are Neutrophils (White Blood Cells)?

White blood cells are part of the body’s immune system and help to protect against infection. White blood cells are made in the bone marrow and can be found in the blood and lymph tissue.

Neutrophils are white blood cells that help protect the body against infection. Once created in the bone marrow, neutrophils travel to any tissue in the body that needs them.

How White Blood Cells Change When Pregnant

When the body is under stress, more neutrophils are released from the bone marrow into the bloodstream. Usually, the neutrophils found in the blood are mature. In times of stress, more immature neutrophils are released into the blood.

Immature neutrophils are known as band neutrophils due to their segmented band-like shape. Band neutrophils can be detected in a blood test. The bone marrow tends to release more bands into the blood in response to the increased number of red blood cells produced during pregnancy.

Why Neutrophils Are High During Pregnancy

Neutrophils increase in the bloodstream during pregnancy because of the changes happening in the body. You can think of neutrophils as first responders. Any time your immune system detects a foreign body, it sends neutrophils to the blood. A release of neutrophils can trigger inflammation in the body.

A typical range of white blood cells in healthy adults is 4,500 to 11,000 neutrophils per microliter. Any value above 11,000 neutrophils per microliter is considered a high white blood cell count ( l eukocytosis). During pregnancy, the white blood cell count usually increases to a range of 13,200 to 15,900 neutrophils per microliter. Most of the increased white blood cells in the bloodstream are neutrophils.

After a vaginal delivery, the WBC count drops to about 12,620 neutrophils per microliter. The value after a cesarean section (C-section) is about 12,710 neutrophils per microliter.

Newborns also have higher WBC counts than most healthy adults. A typical range for a newborn baby is 13,000 to 38,000 neutrophils per microliter. A normal range for a 2-week-old is 5,000 to 20,000 neutrophils per microliter. The number of white blood cells in the blood decrease throughout childhood until it reaches a normal adult range of 4,500 to 1,000 neutrophils per microliter.

Medications

Medications that can raise the WBC count include:

• Corticosteroids
• Beta-agonists
• Colony-stimulating factors
• Epinephrine
• Lithium

Symptoms of a High WBC Count When Pregnant

It is normal to have a high white blood cell count during pregnancy. There are usually no signs or symptoms that can be felt or detected.

Signs and symptoms of an elevated WBC count in non-pregnant adults may include:

• Fever
• Swelling
• Bruising
• Bleeding
• Fatigue
• Weakness
• Night sweats
• Unintentional weight loss

When to Seek Treatment

Many pregnant individuals experience more white blood cells during their pregnancies. It’s important to note that the WBC count can also be elevated for other reasons. Serious conditions, such as certain malignancies, may increase the WBC count.

Signs of a serious condition may include:

• Fever
• New-onset pain
• Severe fatigue
• Night sweats
• Easy bruising or bleeding
• Any weight loss
• Breathing difficulties

An increased neutrophil count during pregnancy may also be linked to gestational diabetes. There are usually no signs or symptoms to look for with this condition. It’s important to receive regular prenatal care so your healthcare provider can detect pregnancy complications as soon as possible.

Summary

Neutrophils are a type of white blood cell that helps our bodies fight off infection. During pregnancy, the number of neutrophils in the blood naturally increases in response to the extra stress that pregnancy puts on a person’s body.

A normal range of white blood cells in healthy, non-pregnant adults is 4,500 to 11,000 neutrophils per microliter. The WBC count may increase during pregnancy and range from 13,200 to 15,900 neutrophils per microliter. Most of the increased white blood cells in the bloodstream are neutrophils.

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

1. Vokalova L, van Breda S, Ye X, et al. Excessive neutrophil activity in gestational diabetes mellitus: Could it contribute to the development of preeclampsia?Front Endocrinol (Lausanne). 2018 Sep;9(1):542. doi:10.3389/fendo.2018.00542
2. National Cancer Institute. Definition of white blood cell.
3. Rosales C. Neutrophil: A cell with many roles in inflammation or several cell types?Front Physiol. 2018 Feb;9(1):113. doi:10.3389/fphys.2018.00113
4. Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus. 2012;28(3):144-146. doi:10.1007/s12288-012-0175-6
5. Bert S, Ward EJ, Nadkarni S. Neutrophils in pregnancy: new insights into innate and adaptive immune regulation. Immunology. 2021;164(4):665-676. doi:10.1111/imm.13392
6. University of California San Francisco. WBC count.
7. Arbib N, Aviram A, Gabbay Ben-Ziv R, Sneh O, Yogev Y, Hadar E. The effect of labor and delivery on white blood cell count. J Matern Fetal Neonatal Med. 2016;29(18):2904-2908.
8. Riley LK, Rupert J. Evaluation of patients with leukocytosis. Am Fam Physician. 2015;92(11):1004-1011.
9. Sun T, Meng F, Zhao H, et al. Elevated first-trimester neutrophil count is closely associated with the development of maternal gestational diabetes mellitus and adverse pregnancy outcomes. Diabetes. 2020;69(7):1401-1410. doi:10.2337/db19-0976

By Carrie Madormo, RN, MPH
Madormo is a health writer with over a decade of experience as a registered nurse. She has worked in pediatrics, oncology, chronic pain, and public health.

Physiological Changes in Hematological Parameters During Pregnancy

Received 2012 Apr 14; Accepted 2012 Jun 21; Issue date 2012 Sep.

© Indian Society of Haematology and Transfusion Medicine 2012
PMCID: PMC3422383 PMID: 23997449

Abstract

Pregnancy is a state characterized by many physiological hematological changes, which may appear to be pathological in the non-pregnant state. The review highlights most of these changes along with the scientific basis for the same, as per the current knowledge, with a special reference to the red blood and white blood cells, platelets and hemostatic profile.

Keywords: Pregnancy, Physiological, Hematological changes

Physiological changes in pregnancy and puerperium are principally influenced by changes in the hormonal milieu. Many hematological changes also, occurring during these periods are physiological and are of inconsequential concern to the hematologist.

Red Blood Cells

During pregnancy, the total blood volume increases by about 1.5 liters, mainly to supply the demands of the new vascular bed and to compensate for blood loss occurring at delivery [1]. Of this, around one liter of blood is contained within the uterus and maternal blood spaces of the placenta. Increase in blood volume is, therefore, more marked in multiple pregnancies and in iron deficient states. Expansion of plasma volume occurs by 10–15 % at 6–12 weeks of gestation [2, 3]. During pregnancy, plasma renin activity tends to increase and atrial natriuretic peptide levels tend to reduce, though slightly. This suggests that, in pregnant state, the elevation in plasma volume is in response to an underfilled vascular system resulting from systemic vasodilatation and increase in vascular capacitance, rather than actual blood volume expansion, which would produce the opposite hormonal profile instead (i.e., low plasma renin and elevated atrial natriuretic peptide levels) [4, 5].

Red cell mass (driven by an increase in maternal erythropoietin production) also increases, but relatively less, compared with the increase in plasma volume, the net result being a dip in hemoglobin concentration. Thus, there is dilutional anemia. The drop in hemoglobin is typically by 1–2 g/dL by the late second trimester and stabilizes thereafter in the third trimester, when there is a reduction in maternal plasma volume (owing to an increase in levels of atrial natriuretic peptide). Women who take iron supplements have less pronounced changes in hemoglobin, as they increase their red cell mass in a more proportionate manner than those not on hematinic supplements.

The red blood cell indices change little in pregnancy. However, there is a small increase in mean corpuscular volume (MCV), of an average of 4 fl in an iron-replete woman, which reaches a maximum at 30–35 weeks gestation and does not suggest any deficiency of vitamins B12 and folate. Increased production of RBCs to meet the demands of pregnancy, reasonably explains why there is an increased MCV (due to a higher proportion of young RBCs which are larger in size). However, MCV does not change significantly during pregnancy and a hemoglobin concentration

Post pregnancy, plasma volume decreases as a result of diuresis, and the blood volume returns to non-pregnant values. Hemoglobin and hematocrit increase consequently. Plasma volume increases again two to five days later, possibly because of a rise in aldosterone secretion. Later, it again decreases. Significant elevation has been documented between measurements of hemoglobin taken at 6–8 weeks postpartum and those taken at 4–6 months postpartum, indicating that it takes at least 4–6 months post pregnancy, to restore the physiological dip in hemoglobin to the non-pregnant values [7].

White Blood Cells

White blood cell count is increased in pregnancy with the lower limit of the reference range being typically 6,000/cumm. Leucocytosis, occurring during pregnancy is due to the physiologic stress induced by the pregnant state [8]. Neutrophils are the major type of leucocytes on differential counts [9, 10]. This is likely due to impaired neutrophilic apoptosis in pregnancy [9]. The neutrophil cytoplasm shows toxic granulation. Neutrophil chemotaxis and phagocytic activity are depressed, especially due to inhibitory factors present in the serum of a pregnant female [11]. There is also evidence of increased oxidative metabolism in neutrophils during pregnancy. Immature forms as myelocytes and metamyelocytes may be found in the peripheral blood film of healthy women during pregnancy and do not have any pathological significance [12]. They simply indicate adequate bone marrow response to an increased drive for erythropoesis occurring during pregnancy.

Lymphocyte count decreases during pregnancy through the first and second trimesters and increases during the third trimester. There is an absolute monocytosis during pregnancy, especially in the first trimester, but decreases as gestation advances. Monocytes help in preventing fetal allograft rejection by infiltrating the decidual tissue (7th–20th week of gestation) possibly, through PGE2 mediated immunosuppression [13]. The monocyte to lymphocyte ratio is markedly increased in pregnancy. Eosinophil and basophil counts, however, do not change significantly during pregnancy [14].

The stress of delivery may itself lead to brisk leucocytosis. Few hours after delivery, healthy women have been documented as having a WBC count varying from 9,000 to 25,000/cumm. By 4 weeks post-delivery, typical WBC ranges are similar to those in healthy non-pregnant women.

Platelets

Large cross-sectional studies done in pregnancy of healthy women (specifically excluding any with hypertension) have shown that the platelet count does decrease during pregnancy, particularly in the third trimester. This is termed as “gestational thrombocytopenia.” It is partly due to hemodilution and partly due to increased platelet activation and accelerated clearance [15]. Gestational thrombocytopenia does not have complications related to thrombocytopenia and babies do not have severe thrombocytopenia (platelet count ≤20,000/cumm). It has hence been recommended that the lower limit of platelet count in late pregnancy should be considered as 1.15 lac/cumm [1]. The platelet volume distribution width increases significantly and continuously as gestation advances, for reasons cited before. Thus, with advancing gestation, the mean platelet volume becomes an insensitive measure of the platelet size.

Post delivery platelet count increases in reaction to and as a compensation for increased platelet consumption during the process of delivery.

Hemostatic Profile

Pregnancy is associated with significant changes in the hemostatic profile. Fibrinogen and clotting factors VII, VIII, X, XII, vWF and ristocetin co-factor activity increase remarkably as gestation progresses. Increased levels of coagulation factors are due to increased protein synthesis mediated by the rising estrogen levels. In in vitro experiments, pregnant plasma has been demonstrated to be capable of increased thrombin generation [16]. Thus, pregnancy is a prothrombotic state. In pregnancy, aPTT is usually shortened, by up to 4 s in the third trimester, largely due to the hormonally influenced increase in factor VIII. However, no marked changes in PT or TT occur [1].

There are changes in the levels and activity of the natural anticoagulants also. Levels and activity of Protein C do not change and remain within the same range as for non-pregnant women of similar age. Levels of total and free (i.e., biologically available) Protein S, decrease progressively with the advancement of gestation. Antithrombin levels and activity are usually stable throughout the pregnancy, fall during labor and rise again soon after delivery. Acquired activated Protein C (APC) resistance has been found to occur in pregnancy, even when Factor V Leiden and antiphospholipid antibodies are not present. [18]. This has been attributed to the high factor VIII and factor V activity and low free Protein S levels. Hence, APC sensitivity ratio does not serve as a screening test for Factor V Leiden during pregnancy.

Coagulation factors remain elevated for up to 8–12 weeks post partum and assays for them may be falsely negative during this period.

Markers of hemostatic activity which are clinically relevant are thrombin–antithrombin complexes (TAT) and prothrombin fragments (F 1 + 2), which reflect in vivo thrombin formation, as also, tests which demonstrate plasmin degradation of fibrin polymer to yield fragments, namely D-dimer and fibrin degradation products (FDP) assay. TAT levels increase with gestation; in early pregnancy the upper limit of normal is similar to the adult range of 2.63 g/L, whereas by term, the upper limit of normal is 18.03 g/L. D-dimer levels are markedly increased in pregnancy, with typical reference range being tenfold higher in late pregnancy than in early pregnancy or in the nonpregnant state [1]. The increase in D-dimers reflects the overall increase in total amount of fibrin during pregnancy consequent to increased thrombin generation, increased fibrinolysis or a combination of both [17]. This also explains why the D-dimer assay is not reliable for predicting the possibility of venous thrombo-embolism in pregnant patients [13].

References

• 1. Ramsay Margaret. Normal hematological changes during pregnancy and the puerperium. In: Pavord S, Hunt B, editors. The obstetric hematology manual. Cambridge: Cambridge University Press; 2010. pp. 1–11. [Google Scholar]
• 2. Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. J Obstet Gynecol. 2001;97:669. doi: 10.1016/S0029-7844(00)01222-9. [DOI] [PubMed] [Google Scholar]
• 3. Bjorksten B, Soderstrom T, Damber M-G, Schoultz B, Stigbrand T. Polymorphonuclear leucocyte function during pregnancy. Scand J Immunol. 1978;8(3):257–262. doi: 10.1111/j.1365-3083.1978.tb00518.x. [DOI] [PubMed] [Google Scholar]
• 4. Ajzenberg N, Dreyfus M, Kaplan C, Yvart J, Weill B, Tchernia G. Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. Blood. 1998;92(12):4573–4580. [PubMed] [Google Scholar]
• 5. Barriga C, Rodriguez AB, Orega E. Increased phagocytic activity of polymorphonuclear leucocytes during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1994;57(1):43–46. doi: 10.1016/0028-2243(94)90109-0. [DOI] [PubMed] [Google Scholar]
• 6. Crocker IP, Baker PN, Fletcher J. Neutrophil function in pregnancy and rheumatoid arthritis. Ann Rheumat Dis. 2000;59:555–564. doi: 10.1136/ard.59.7.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
• 7. Taylor DJ, Lind T. Red cell mass during and after normal pregnancy. Br J Obstet Gynecol. 1979;86:364–370. doi: 10.1111/j.1471-0528.1979.tb10611.x. [DOI] [PubMed] [Google Scholar]
• 8. Fleming AF. Hematological changes in pregnancy. Clin Obstet Gynecol. 1975;2:269. [Google Scholar]
• 9. Gatti L, Tinconi PM, Guarneri D, Bertuijessi C, Ossola MW, Bosco P, Gianotti G. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Internat J Clin Lab Res. 1994;24(4):217–219. doi: 10.1007/BF02592466. [DOI] [PubMed] [Google Scholar]
• 10. Konijnenberg A, Stokkers E, Post J. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol. 1997;176(2):461–469. doi: 10.1016/S0002-9378(97)70516-7. [DOI] [PubMed] [Google Scholar]
• 11. Jessica M, Badger F, Hseih CC, Troisi R, Lagiou P, Polischman N. Plasma volume expansion in pregnancy: implications for biomarkers in population studies. Cancer Epidemiol Biomarkers. 2007;16:1720. doi: 10.1158/1055-9965.EPI-07-0311. [DOI] [PubMed] [Google Scholar]
• 12. Karalis L, Nadan S, Yemen EA. Platelet activation in pregnancy induced hypertension. Thromb Res. 2005;116(5):377–383. doi: 10.1016/j.thromres.2005.01.009. [DOI] [PubMed] [Google Scholar]
• 13. Kline AJ, Williams GW, Hernandez-Nino J. D-Dimer concentration in normal pregnancy: new diagnostic thresholds are needed. Clin Chem. 2005;51(5):825–829. doi: 10.1373/clinchem.2004.044883. [DOI] [PubMed] [Google Scholar]
• 14. Edlestam G, Lowbeer C, Kral G, et al. New reference values for routine blood samples and human neutrophilic lipocalin during third trimester pregnancy. Scand J Clin Lab Inv. 2001;61:583–592. doi: 10.1080/003655101753267937. [DOI] [PubMed] [Google Scholar]
• 15. Shehlata N, Burrows RF, Kelton JG. Gestational thrombocytopenia. Clin Obstet Gynecol. 1999;42:327–334. doi: 10.1097/00003081-199906000-00017. [DOI] [PubMed] [Google Scholar]
• 16. Boer K, Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1989;160(1):95–100. doi: 10.1016/0002-9378(89)90096-3. [DOI] [PubMed] [Google Scholar]
• 17. Eichinger S. D-dimer testing in pregnancy. Pathophysiol Hemost Thromb. 2004;33:327–329. doi: 10.1159/000083822. [DOI] [PubMed] [Google Scholar]
• 18. Clark P, Brennard J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Hemost. 1998;79:1166–1170. [PubMed] [Google Scholar]

Articles from Indian Journal of Hematology and Blood Transfusion are provided here courtesy of Springer

ACTIONS

• View on publisher site
• PDF (133.5 KB)
• Cite
• Collections
• Permalink